Analysis of sulfated polysaccharides

Details Analysis of sulfated polysaccharides Analysis of sulfated polysaccharides

2011-05-24

2011-05-24

Prouty, Rebecca E. (Department: 1657)

Chemistry: analytical and immunological testing

Nitrogen containing

C436S173000, C436S161000

Reexamination Certificate

active

07947507

ABSTRACT:
The invention relates to methods and products associated with analyzing and monitoring heterogeneous populations of sulfated polysaccharides. In particular therapeutic heparin products including low molecular weight heparin products and methods of analyzing and monitoring these products are described.

REFERENCES:
patent: 3832253 (1974-08-01), DiPalma
patent: 3854480 (1974-12-01), Zaffaroni
patent: 4452775 (1984-06-01), Kent
patent: 4652555 (1987-03-01), Goulay
patent: 4667014 (1987-05-01), Nestor et al.
patent: 4686288 (1987-08-01), Lormeau
patent: 4687765 (1987-08-01), Vairel
patent: 4692435 (1987-09-01), Lormeau
patent: 4748034 (1988-05-01), De Rham
patent: 4791195 (1988-12-01), Bianchini
patent: 4826827 (1989-05-01), Lormeau
patent: 4847338 (1989-07-01), Lindhardt
patent: 4916219 (1990-04-01), Lindhardt
patent: 4933326 (1990-06-01), Bianchini
patent: 4977250 (1990-12-01), Diaz
patent: 4981955 (1991-01-01), Lopez-Belmonte
patent: 4990502 (1991-02-01), Lormeau
patent: 5010063 (1991-04-01), Piani
patent: 5013724 (1991-05-01), Petitou
patent: 5013725 (1991-05-01), Isomura
patent: 5019649 (1991-05-01), Lormeau
patent: 5032679 (1991-07-01), Brandley
patent: 5039529 (1991-08-01), Bergendal
patent: 5084564 (1992-01-01), Vila
patent: 5104860 (1992-04-01), Piani
patent: 5106734 (1992-04-01), Nielsen
patent: 5110918 (1992-05-01), Casu
patent: 5164378 (1992-11-01), Conti
patent: 5239660 (1993-08-01), Ooi
patent: 5264425 (1993-11-01), Dal Pozzo
patent: 5296471 (1994-03-01), Holme
patent: 5340932 (1994-08-01), Fussi
patent: 5380716 (1995-01-01), Conrad
patent: 5389618 (1995-02-01), Debrie
patent: 5403827 (1995-04-01), De-Ambrosi
patent: 5410039 (1995-04-01), Ungarelli
patent: 5430132 (1995-07-01), Silvano
patent: 5430133 (1995-07-01), Piani
patent: 5599801 (1997-02-01), Branellec
patent: 5668118 (1997-09-01), Kennedy
patent: 5696100 (1997-12-01), Holme
patent: 5707973 (1998-01-01), Baron
patent: 5707974 (1998-01-01), Kennedy
patent: 5721973 (1998-02-01), Mizukawa
patent: 5763421 (1998-06-01), Caretto
patent: 5767269 (1998-06-01), Hirsh
patent: 5783570 (1998-07-01), Yokota
patent: 5808021 (1998-09-01), Holme
patent: 5849721 (1998-12-01), Uzan
patent: 5912237 (1999-06-01), Kennedy
patent: 5922358 (1999-07-01), Doutremepuich
patent: 5935850 (1999-08-01), Clark
patent: 5958899 (1999-09-01), Zoppetti
patent: 6075013 (2000-06-01), Weitz
patent: 6077683 (2000-06-01), Kennedy
patent: 6143730 (2000-11-01), Parish
patent: 6197943 (2001-03-01), Casu
patent: 6228998 (2001-05-01), Miura
patent: 6232093 (2001-05-01), Van Houdenhoven
patent: 6255296 (2001-07-01), Daniels
patent: 6258798 (2001-07-01), Wallentin
patent: 6384021 (2002-05-01), Mardiguian
patent: 6492503 (2002-12-01), Kariya
patent: 6617316 (2003-09-01), Mourier et al.
patent: RE38743 (2005-06-01), Debrie
patent: 7083937 (2006-08-01), Sasisekharan et al.
patent: 2004/0265943 (2004-12-01), Viskov et al.
patent: 2005/0119477 (2005-06-01), Mourier et al.
patent: 2005/0186679 (2005-08-01), Viskov et al.
patent: 2005/0215519 (2005-09-01), Viskov et al.
patent: 2006/0024664 (2006-02-01), Sasisekharan et al.
patent: 2007/0161073 (2007-07-01), Sasisekharan et al.
patent: 121067 (1987-04-01), None
patent: 244236 (1987-04-01), None
patent: 244235 (1993-01-01), None
patent: 245813 (1993-03-01), None
patent: 302034 (1993-04-01), None
patent: 268885 (1993-05-01), None
patent: 423151 (1993-09-01), None
patent: 293539 (1994-06-01), None
patent: 347588 (1994-07-01), None
patent: 380943 (1994-09-01), None
patent: 432537 (1995-01-01), None
patent: 483733 (1996-08-01), None
patent: 623629 (1996-08-01), None
patent: 625166 (1997-09-01), None
patent: 557887 BI (1997-12-01), None
patent: 708785 (1999-03-01), None
patent: 693499 (1999-12-01), None
patent: 789777 (2000-08-01), None
patent: 970130 (2002-07-01), None
patent: 735050 (2002-09-01), None
patent: 1580197 (2005-09-01), None
patent: 1582531 (2005-10-01), None
patent: 1586588 (2005-10-01), None
patent: WO 88/09347 (1988-12-01), None
patent: WO 90/03791 (1990-04-01), None
patent: WO 99/14326 (1999-03-01), None
patent: WO 00/65521 (2000-11-01), None
patent: WO 01/29055 (2001-04-01), None
patent: WO 02/23190 (2002-03-01), None
patent: WO 02/32406 (2002-04-01), None
patent: WO 2004/027087 (2004-04-01), None
patent: WO 2005/080438 (2005-09-01), None
patent: WO 2005/090411 (2005-09-01), None
Saad et al. Compositional Analysis and Quantification of Heparin and Heparin Sulfate by Electrospray Ionization Ion Trap Mass Spectrometry; Analytical Chemistry, vol. 75 (2003) pp. 2985-2995.
Bottio et al. Life-Threatening Anaphylactic Shock Caused by Porcine Heparin Intravenous Infusion During Mitral Valve Repair; The Journal of Thoracic and Cardiovascular Surgery, vol. 126 (2003) pp. 1194-1195.
Dalmora et al. Biological Potency and Physicochemical Characterization of Unfractionated Heparins; Revista Brasileira de Hematologi e Hematerapia, vol. 31, No. 4 (2009) pp. 1-7.
Aarnoudse et al. “Interleukin-2-induced, melanoma-specific T cells recognize CAMEL, an unexpected translation product of LAGE-1”Int. J. Cancer82:442-448 (1999).
Anumula et al. “High resolution and high sensitivity methods for oligosaccharide mapping and characterization by normal phase high performance liquid chromatography following derivatization with highly fluorescent anthranilic acid”Glycobiology8(7):685-694 (1998).
Araki et al. “Application of 2-aminopyridine fluorescence labeling in the analysis of in vivo and in vitro metabolism of dextran sulfate sodium by size-exclusion high-performance liquid chromatorgraphy”J Chromatogr B Biomed Sci753(2):209-215 (2001).
Bennett et al. “High Resolution Analysis of Functional Determinants on Human Tissue-type Plasminogen Activator”J. of Biological Chemistry266(8):5191-5201 (1991).
Bigge et al. “Nonselective and efficient fluorescent labeling of glycans using 2-amino benzamide and anthranilic acid”Anal Biochem230(2):229-238 (1995).
Binari et al. “Genetic evidence that heparin-like glycosaminoglycans are involved in wingless signaling”Development124:2623-2632 (1997).
Boël et al. “BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes”Immunity2:167-175 (1995).
Bosch et al. “Recognition of BCR-ABL Positive Leukemic Blasts by Human CD4÷T Cells Elicited by Primary In Vitro Immunization with a BCR-ABL Breakpoint Peptide”Blood88:3522-3527 (1996).
Brändle et al. “A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma”J. Exp. Med. 183:2501-2508 (1996).
Brichard et al. “A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes”Eur. J. Immunol. 26:224-230 (1996).
Brossart et al. “Her-2
eu-derived peptides are tumor-associated antigens expressed by human renal cell and colon carcinoma lines and are recognized by in vitro induced specific cytotoxic T lymphocytes”Cancer Res. 58:732-736 (1998).
Carlson et al. “The Determination of Recombinant Human Tissue-Type Plasminogen Activator Activity by Turbidimetry Using a Microcentrifugal Analyzer”Analytical Biochem. 168:428-435 (1988).
Castelli et al. “Mass Spectromic Identification of a Naturally Processed Melanoma Peptide Recognized by CD8+Cytotoxic T Lymphocytes”J. Exp. Med. 181:363-368 (1995).
Castelli et al. “Novel HLA-Cw8-Restricted T Cell Epitopes Derived from Tyrosinase-Related Protein-2 and gp100 Melanoma Antigens”J. Immunol. 162:1739-1748 (1999).
Chaux et al. “Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes”J. Exp. Med. 189:767-778 (1999).
Chaux et al. “Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1”J. Immunol. 163:2928-2936 (1999).
Chiari et al. “Two Antigens Recognized by Autologous Cytolytic T Lymphocytes on a Melanoma Result form a Sing

Affiliated with

Also associated with

Rating

Analysis of sulfated polysaccharides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Analysis of sulfated polysaccharides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Analysis of sulfated polysaccharides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2707685